Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
about
Toxicity testing in the 21st century: a vision and a strategyLiterature mining for the discovery of hidden connections between drugs, genes and diseasesFunctional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes.Systems biology by the rules: hybrid intelligent systems for pathway modeling and discovery.AnEnPi: identification and annotation of analogous enzymes.An exploratory pathways analysis of temporal changes induced by spinal cord injury in the rat bladder wall: insights on remodeling and inflammation.Mapping the human toxome by systems toxicology.Proteogenomic convergence for understanding cancer pathways and networks.Identification of novel conserved functional motifs across most Influenza A viral strainsAre orphan genes protein-coding, prediction artifacts, or non-coding RNAs?Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders.Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals.Cellular imaging in drug discovery.The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics researchGlobal metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century.Nanovehicular intracellular delivery systems.In silico promoters: modelling of cis-regulatory context facilitates target predictio.Application of pressurized solvents for ultrafast trypsin hydrolysis in proteomics: proteomics on the fly.Quantitative knowledge-based analysis in compound safety assessment.Alzheimer's disease drug development: translational neuroscience strategies.A microfluidic dual gradient generator for conducting cell-based drug combination assays.Revealing a signaling role of phytosphingosine-1-phosphate in yeastDiscovery DMPK: changing paradigms in the eighties, nineties and noughties.Integrated proteomics and genomics strategies bring new insight into Candida albicans response upon macrophage interaction.Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials.Linking Life Sciences Data Using Graph-Based Mapping
P2860
Q27921848-1ECCEA72-E278-4143-BCA7-6E4CEE645753Q28475561-3A89252F-2FC6-4252-9D1B-9A59B83FB3C6Q30496004-C932E192-F0E6-4564-BC23-3C27220FB3A4Q33281131-14E4279F-3BFA-46E8-BED6-6DAD74EC49B5Q33394033-CA496E72-636F-4C9E-A914-0C1139CA50D7Q33464962-3C3D4F5B-09EB-427F-AC04-5B32FAF10F61Q33734846-8946DE5F-2A47-4188-8B2F-0204A0EB7700Q33792433-77E8B892-F76F-4525-B079-0EB65EA38D69Q34564391-FADCD8C8-9A05-4230-95A7-6979512A7527Q36035025-B83A57B0-74F6-4EE3-8CFC-A41DD11104A1Q36087088-6C1DB390-EBDF-4C63-88A7-939DB1418ABFQ36407441-17D3C5C8-0531-4C5F-A7C3-4CF05D3D1209Q36438745-36500EE9-CFEF-4BF9-BB0B-1A0C653894AAQ36667345-68D357F2-0884-4142-B836-6FAA3AB6B68CQ36816026-FF310888-2549-4CA6-9CED-BEC28EA5F46AQ37058812-14189809-2BB9-4FC0-97A1-E94418D94610Q37174211-51794116-FE31-48C2-B214-E8DC3A33B79EQ37347394-21D015B3-01C7-4085-A2E6-2AA22DDA8F47Q37831322-6EF67FB2-1AEB-4967-AE7E-FD02AA42FEB2Q38087640-AF82DB43-DD21-4F63-93C3-CFB9EA8501C8Q38819479-5D538A03-E42A-4B4F-BD2B-10018E382ACDQ39521819-84397719-FB42-4F8E-B97C-03D842EB662DQ39998934-08064C41-FD6F-462C-A9D0-8A40D4E90D1EQ40197295-D1567DDC-9F43-4067-A809-14ED0E3343BAQ42359116-EB13ADF4-21C1-4C68-AF74-F65F32865E09Q55103799-A19DD363-C5DD-4F58-94EF-8324C1A3C020Q57240839-F00E2B13-9FD3-4BA3-AA5E-C977049B9049
P2860
Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Towards quantitative biology: ...... s and to guide drug discovery.
@ast
Towards quantitative biology: ...... s and to guide drug discovery.
@en
type
label
Towards quantitative biology: ...... s and to guide drug discovery.
@ast
Towards quantitative biology: ...... s and to guide drug discovery.
@en
prefLabel
Towards quantitative biology: ...... s and to guide drug discovery.
@ast
Towards quantitative biology: ...... s and to guide drug discovery.
@en
P1476
Towards quantitative biology: ...... s and to guide drug discovery.
@en
P2093
Hans Peter Fischer
P356
10.1016/S1387-2656(05)11001-1
P577
2005-01-01T00:00:00Z